CCL20/MIP-3 alpha Antibody (4N5F7) [PE]
Novus Biologicals | Catalog # NBP2-27142PE
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Reactivity Notes
Clonality
Host
Isotype
Applications for CCL20/MIP-3 alpha Antibody (4N5F7) [PE]
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: CCL20/MIP-3 alpha
Alternate Names
Gene Symbol
Additional CCL20/MIP-3 alpha Products
Product Documents for CCL20/MIP-3 alpha Antibody (4N5F7) [PE]
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for CCL20/MIP-3 alpha Antibody (4N5F7) [PE]
This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Related Research Areas
Customer Reviews for CCL20/MIP-3 alpha Antibody (4N5F7) [PE]
There are currently no reviews for this product. Be the first to review CCL20/MIP-3 alpha Antibody (4N5F7) [PE] and earn rewards!
Have you used CCL20/MIP-3 alpha Antibody (4N5F7) [PE]?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Cellular Response to Hypoxia Protocols
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars